Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations by Alaa Elwan, Helmy Sakr, Abdel-Ghany A. El-Helby, Ahmed El-morsy, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Mohamed El-Sherbiny, Khaled El-Adl

Subjects: Get full text

New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies by Asmaa H. Mohamed, Mohammed B. Alshammari, Ashraf A. Aly, Kamal U. Sadek, Akil Ahmad, Eman A. Aziz, Amira F. El-Yazbi, Eman J. El-Agroudy, Marwa E. Abdelaziz

Subjects: Get full text

Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia by Dipak Walunj, Katarina Egarmina, Adi Zipin-Roitman, Siva Sai Naga Anurag Muddineni, Iryna Tkachenko, Pousali Mitra, Dror Tobi, Andrii Bazylevich, Ofer Shpilberg, Michael Milyavsky, Oshrat Hershkovitz-Rokah, Gary Gellerman

Subjects: Get full text

Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation by K. I. Kirsanov, O. A. Vlasova, T. I. Fetisov, R. G. Zenkov, E. A. Lesovaya, G. A. Belitsky, K. Gurova, M. G. Yakubovskaya

Subjects: Get full text